000 00823 a2200229 4500
005 20250516103219.0
264 0 _c20140627
008 201406s 0 0 eng d
022 _a1873-233X
024 7 _a10.1097/AOG.0b013e318268049e
_2doi
040 _aNLM
_beng
_cNLM
245 0 0 _aCommittee opinion No. 532: compounded bioidentical menopausal hormone therapy.
_h[electronic resource]
260 _bObstetrics and gynecology
_cAug 2012
300 _a411-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDrug Compounding
650 0 4 _aEstrogen Replacement Therapy
650 0 4 _aFemale
650 0 4 _aHumans
773 0 _tObstetrics and gynecology
_gvol. 120
_gno. 2 Pt 1
_gp. 411-5
856 4 0 _uhttps://doi.org/10.1097/AOG.0b013e318268049e
_zAvailable from publisher's website
999 _c21968607
_d21968607